Notably, CCL3 enhances osteoclastogenesis by signalling through CCR1 and CCR5 receptors and has been implicated in the osteolytic activity observed in pathological conditions such as multiple myeloma [49]. The gene discussed is CCL3; the disease is plasma cell myeloma.